The use of "Inhaler" Risk of Death

Most people with asthma would have been familiar with inhalers or inhaled medications. Inhaler is a medical tool that is used to deliver drugs into the body through the lungs. However, recent research from the British Medical Journal shows, the use of inhalers containing tiotropium bromide may increase the risk of death in people with bronchitis or emphysema. The results also show, as much as 52 percent of those taking tiotropium inhaler risk of death than those taking placebo.

"What we think is a tiotropium inhaler provides a higher concentration than it should. This can increase the risk of death," said Dr. Sonal Singh of Johns Hopkins University School of Medicine. According to Singh, in the United States and elsewhere, the drug is available in powder form and sold under the brand name Spiriva. These drugs are commonly used to treat chronic obstructive pulmonary disease. However, in 55 other countries, tiotropium drugs marketed in the form of inhalers. Agency for the United States Food and Drug Administration (FDA) has not given approval for the circulation of tiotropium inhaler. However, most patients actually have used it. 

Sigh added, the use of inhalers will be more dangerous when used by people suffering from cardiovascular disease. The reason, including in the tiotropium group anticholinergic drugs, which can increase the risk of heart rhythm disturbances (arrhythmias), especially for those who have a history of heart attack.

"I am very concerned with the use of inhalers. They are not fully informed about the risks that could result from the use of  it," continued Singh.

Based on recent studies involving 6,500 people, the results showed, at least one death every year, from 124 patients who had been treated with tiotropium inhaler. Chronic obstructive pulmonary disease has so far ranked fourth as a cause of death worldwide, including pulmonary emphysema, bronchitis, which is generally caused by smoking. During this time, the use of tiotropium are routinely given to patients with chronic obstructive pulmonary disease with symptoms such as shortness of breath.

According to researchers, shortness of breath caused by chronic obstructive pulmonary disease can be treated using bronchodilators. The use of bronchodilators was allegedly able to reduce the risk of chronic lung disease and is much safer. Furthermore, Singh said the chronic pulmonary patient should consult with their doctor about what medications are safe and should be used.

Related :